January 19, 2021
Only one in 5,000 discovery compounds will reach the market. In the most recent Formulation Forum, Ascendia Pharma CEO Jim […]
READ MORE >
Sophisticated formulations in every stage of development from MOLECULE to FORMULATION to CLINICAL 
Our Technologies
EMULSOL
AMORSOL
NANOSOL
A wide array of pharmaceutical development capabilities for manufacturing and
analyzing drug product dosage forms. READ MORE >
FEATURED
Ascendia Ranks on Annual List of America’s Fastest-Growing Private Companies—the Inc. 5000
Inc. magazine announces that Ascendia has made the annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing […]
READ MOREPARTNERING WITH ASCENDIA
Ascendia provides its partners rapid, comprehensive and cost-effective
solutions for their difficult formulation development projects. LEARN MORE >
ASCENDIA NEWSROOM
January 12, 2021
Ascendia Pharma, recipient of the prestigious Inc. 5000 award recognizing the top U.S. private companies, is participating in the BIO […]
READ MORE >December 30, 2020
In the most recent Formulation Forum column, Ascendia Pharma founder and CEO Jim Huang, PhD explains the biopharmaceutical considerations and […]
READ MORE >